Pleural Mesotheliomas Active Not Recruiting Phase 2 Trials for Durvalumab (DB11714)

Also known as: Pleural Mesothelioma

IndicationStatusPhase
DBCOND0029910 (Pleural Mesotheliomas)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02899195Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable MesotheliomaTreatment